Search research articles
Contact Us
Filters
Showing results (71-80 of 78) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 78 results.
Annals of Surgical Oncology
|
March 19, 2013
Comparative evaluation of [(99m)tc]tilmanocept for sentinel lymph node mapping in breast cancer patients: results of two phase 3 trials
Anne M Wallace, Linda K Han, Stephen P Povoski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2009
Phase II trial of sorafenib in metastatic thyroid cancer
Richard T Kloos, Matthew D Ringel, Michael V Knopp, et al.
Annals of Surgical Oncology
|
February 12, 2015
[(99m)Tc]Tilmanocept Accurately Detects Sentinel Lymph Nodes and Predicts Node Pathology Status in Patients with Oral Squamous Cell Carcinoma of the Head and Neck: Results of a Phase III Multi-institutional Trial
Amit Agrawal, Francisco J Civantos, Kevin T Brumund, et al.
Cancer
|
March 1, 2014
Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survival
Jonathon B Cohen, Susan M Geyer, Gerard Lozanski, et al.
EJNMMI Research
|
January 20, 2017
A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB-IIIA resectable NSCLC
John P Crandall, Abdel K Tahari, Rosalyn A Juergens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2021
Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial
Karyn A Goodman, Fang-Shu Ou, Nathan C Hall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 7, 2010
Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer
Elaine T Lam, Matthew D Ringel, Richard T Kloos, et al.
The Lancet. Oncology
|
March 1, 2023
Harnessing imaging tools to guide immunotherapy trials: summary from the National Cancer Institute Cancer Imaging Steering Committee workshop
Lalitha K Shankar, Heiko Schöder, Elad Sharon, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 78) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 78 results.
Annals of Surgical Oncology
|
March 19, 2013
Comparative evaluation of [(99m)tc]tilmanocept for sentinel lymph node mapping in breast cancer patients: results of two phase 3 trials
Anne M Wallace, Linda K Han, Stephen P Povoski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2009
Phase II trial of sorafenib in metastatic thyroid cancer
Richard T Kloos, Matthew D Ringel, Michael V Knopp, et al.
Annals of Surgical Oncology
|
February 12, 2015
[(99m)Tc]Tilmanocept Accurately Detects Sentinel Lymph Nodes and Predicts Node Pathology Status in Patients with Oral Squamous Cell Carcinoma of the Head and Neck: Results of a Phase III Multi-institutional Trial
Amit Agrawal, Francisco J Civantos, Kevin T Brumund, et al.
Cancer
|
March 1, 2014
Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survival
Jonathon B Cohen, Susan M Geyer, Gerard Lozanski, et al.
EJNMMI Research
|
January 20, 2017
A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB-IIIA resectable NSCLC
John P Crandall, Abdel K Tahari, Rosalyn A Juergens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2021
Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial
Karyn A Goodman, Fang-Shu Ou, Nathan C Hall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 7, 2010
Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer
Elaine T Lam, Matthew D Ringel, Richard T Kloos, et al.
The Lancet. Oncology
|
March 1, 2023
Harnessing imaging tools to guide immunotherapy trials: summary from the National Cancer Institute Cancer Imaging Steering Committee workshop
Lalitha K Shankar, Heiko Schöder, Elad Sharon, et al.
Page
of 8